Mylan profits down but revenue up during first quarter

Share with others:


Print Email Read Later

Generic drug maker Mylan Inc. saw first-quarter profits skid 17 percent, to $106.9 million, from $129.1 million in the same period last year as higher expenses for research and development and acquisition-related costs weighed on the bottom line.

Per-share profits fell 10 percent, to 27 cents from 30 cents, reflecting fewer shares outstanding.

Revenue for the three months ended March 31 rose 3 percent, to $1.63 billion from $1.58 billion.

The results were released this afternoon after the close of the stock market.

mobilehome - breaking - businessnews

Patricia Sabatini: psabatini@post-gazette.com or 412-263-3066.


Advertisement
Advertisement
Advertisement

You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here